InvestorsHub Logo
Followers 8
Posts 394
Boards Moderated 0
Alias Born 07/22/2011

Re: NWDR post# 122413

Friday, 09/29/2017 5:42:15 AM

Friday, September 29, 2017 5:42:15 AM

Post# of 461704
Well said. This is my thinking. If you are going to invest in a risky biotech, you should try to find one where, if the company does succeed, the benefits and monetary gains will be substantial. Curing cancer through immunotherapy was once a good risk/reward but today the field is extremely crowded. Yes, Alzheimer's is a difficult nut to crack, but because of this there is a lack of available drugs to treat the disease and hence the bar for approval is low. Just the ability to treat insomnia for those who have the disease should garner approval for A2-73, and if that does not work out, at least AVXL is not a one trick pony. It appears likely to me that eventually this company will get a drug approved, even if there are some setbacks along the way. Patience required....
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News